Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosulpiride Pantoprazole Sodium Injection for Upper Gastrointestinal Ulcer Bleeding
CTR20182336Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Dec 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of s-pantoprazole in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), sponsored by Yangtze River Pharmaceutical Group. Started Dec 2018; status: completed.
02
Drugs
s-pantoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20182336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182336.